ABSTRACT
The roles of imaging in bladder cancer include local staging, detect pelvic and retroperitoneal nodal metastases and, in advanced disease, to identify distant metastases. In patients undergoing systemic or local treatment, imaging is also used to assess treatment response, for surveillance and detecting recurrence. In current practice, magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET)-CT have pre-eminent roles in the management of bladder cancer.
